[Editorial] COVID‑19: Post‑lockdown guidelines

Kostoff,Ronald N.; Briggs,Michael B.; Porter,Alan L.; Aschner,Michael; Spandidos,Demetrios A.; Tsatsakis,Aristidis

doi:10.3892/ijmm.2020.4640

[Editorial] COVID‑19: Post‑lockdown guidelines

Authors:
- Ronald N. Kostoff
- Michael B. Briggs
- Alan L. Porter
- Michael Aschner
- Demetrios A. Spandidos
- Aristidis Tsatsakis
View Affiliations

Affiliations: School of Public Policy, Georgia Institute of Technology, Gainesville, VA 20155, USA, Independent Consultant, Roscommon, MI 48653, USA, School of Public Policy, Georgia Institute of Technology, Atlanta, GA 30332, USA, Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, USA, Laboratory of Clinical Virology, Medical School, University of Crete, 70013 Heraklion, Greece, Laboratory of Toxicology, Medical School, University of Crete, 70013 Heraklion, Greece
Published online on: June 12, 2020 https://doi.org/10.3892/ijmm.2020.4640
Pages: 463-466
Copyright: © Kostoff et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Since March, 2020, in response to the COVID‑19 pandemic, many countries have been on lockdown (at different levels of severity), restricting many activities and businesses that involve gatherings of large numbers of people in close proximity. Currently (early June, 2020), countries across the globe are in different stages of easing lockdown restrictions. Public policies for behaviors and actions during this transition period vary widely across countries and within country jurisdictions. The present editorial will address potential policies that could minimize resurgence of the present pandemic (the ‘second‑wave’) and reduce the likelihood and severity of similar future pandemics.

View Figures

View References

1	Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 395:497–506. 2020. View Article : Google Scholar : PubMed/NCBI
2	Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, Wang Z, Li J, Li J, Feng C, et al: Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 63:364–374. 2020. View Article : Google Scholar : PubMed/NCBI
3	Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H, Xiong Y, Cheng Z, Gao S, Liang K, et al: Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis. Mar 16–2020.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
4	Qian GQ, Yang NB, Ding F, Ma AHY, Wang ZY, Shen YF, Shi CW, Lian X, Chu JG, Chen L, et al: Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series. QJM. Mar 17–2020.Epub ahead of print. View Article : Google Scholar
5	Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, Xie C, Ma K, Shang K, Wang W and Tian DS: Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. Mar 12–2020.Epub ahead of print.
6	Tian S, Hu N, Lou J, Chen K, Kang X, Xiang Z, Chen H, Wang D, Liu N, Liu D, et al: Characteristics of COVID-19 infection in Beijing. J Infect. 80:401–406. 2020. View Article : Google Scholar : PubMed/NCBI
7	Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, Zhang P, Liu X, Gao G, Liu F, et al: Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect. 9:1123–1130. 2020. View Article : Google Scholar : PubMed/NCBI
8	Yun H, Sun Z, Wu J, Tang A, Hu M and Xiang Z: Laboratory data analysis of novel coronavirus (COVID-19) screening in 2510 patients. Clin Chim Acta. 507:94–97. 2020. View Article : Google Scholar : PubMed/NCBI
9	Medetalibeyoğlu A, Şenkal N, Çapar G, Köse M and Tükek T: Characteristics of the initial patients hospitalized for COVID-19: A single-center report. Turk J Med Sci. Jun 3–2020.Epub ahead of print.
10	Guo T, Shen Q, Guo W, He W, Li J, Zhang Y, Wang Y, Zhou Z, Deng D, Ouyang X, et al: Clinical characteristics of elderly patients with COVID-19 in Hunan province, China: A multi-center, retrospective study. Gerontology. May 29–2020.Epub ahead of print. View Article : Google Scholar
11	Docea AO, Tsatsakis A, Albulescu D, Cristea O, Zlatian O, Vinceti M, Moschos SA, Tsoukalas D, Goumenou M, Drakoulis N, et al: A new threat from an old enemy: Re-emergence of coronavirus (Review). Int J Mol Med. 45:1631–1643. 2020.PubMed/NCBI
12	Petrakis D, Margină D, Tsarouhas K, Tekos F, Stan M, Nikitovic D, Kouretas D, Spandidos DA and Tsatsakis A: Obesity a risk factor for increased COVID-19 prevalence, severity and lethality (Review). Mol Med Rep. 22:9–19. 2020.PubMed/NCBI
13	Castle SC, Uyemura K, Rafi A, Akande O and Makinodan T: Comorbidity is a better predictor of impaired immunity than chronological age in older adults. J Am Geriatr Soc. 53:1565–1569. 2005. View Article : Google Scholar : PubMed/NCBI
14	Castle SC, Uyemura K, Fulop T and Makinodan T: Host resistance and immune responses in advanced age. Clinics Geriatric Med. 23:463–479. 2007. View Article : Google Scholar
15	Nitulescu GM, Paunescu H, Moschos SA, Petrakis D, Nitulescu G, Ion GND, Spandidos DA, Nikolouzakis TK, Drakoulis N and Tsatsakis A: Comprehensive analysis of drugs to treat SARS CoV 2 infection: Mechanistic insights into current COVID-19 therapies (Review). Int J Mol Med. 46:467–488. 2020.
16	Stancioiu F, Papadakis GZ, Kteniadakis S, Izotov BN, Coleman MD, Spandidos DA and Tsatsakis A: A dissection of SARS-CoV2 with clinical implications (Review). Int J Mol Med. 46:489–508. 2020.
17	Calina D, Docea AO, Petrakis D, Egorov AM, Ishmukhametov AA, Gabibov AG, Shtilman MI, Kostoff R, Carvalho F, Vinceti M, et al: Towards effective COVID-19 vaccines: Updates, perspectives and challenges (Review). Int J Mol Med. 46:3–16. 2020.
18	Huisman W, Martina BEE, Rimmelzwaan GF, Gruters RA and Osterhaus ADME: Vaccine-induced enhancement of viral infections. Vaccine. 27:505–512. 2009. View Article : Google Scholar
19	Taylor A, Foo S-S, Bruzzone R, Dinh LV, King NJC and Mahalingam S: Fc receptors in antibody-dependent enhancement of viral infections. Immunol Rev. 268:340–364. 2015. View Article : Google Scholar : PubMed/NCBI
20	Wolff GG: Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017-2018 influenza season. Vaccine. 38:350–354. 2020. View Article : Google Scholar
21	Cowling BJ, Fang VJ, Nishiura H, Chan KH, Ng S, Ip DK, Chiu SS, Leung GM and Peiris JS: Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine. Clin Infect Dis. 54:1778–1783. 2012. View Article : Google Scholar : PubMed/NCBI
22	Skowronski DM, Sabaiduc S, Leir S, Rose C, Zou M, Murti M, Dickinson JA, Olsha R, Gubbay JB, Croxen MA, et al: Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV). Euro Surveill. 24:19005852019. View Article : Google Scholar :
23	Kelvin AA and Zambon M: Influenza imprinting in childhood and the influence on vaccine response later in life. Euro Surveill. 24:19007202019. View Article : Google Scholar :
24	Benn CS, Netea MG, Selin LK and Aaby P: A small jab - a big effect: Nonspecific immunomodulation by vaccines. Trends Immunol. 34:431–439. 2013. View Article : Google Scholar : PubMed/NCBI
25	Rakebrandt N and Joller N: Infection history determines susceptibility to unrelated diseases. BioEssays. 41:e18001912019. View Article : Google Scholar : PubMed/NCBI
26	Demars A, Lison A, Machelart A, Van Vyve M, Potemberg G, Vanderwinden JM, De Bolle X, Letesson JJ and Muraille E: Route of infection strongly impacts the host-pathogen relationship. Front Immunol. 10:15892019. View Article : Google Scholar : PubMed/NCBI
27	Pascual DW, Yang X, Wang H, Goodwin Z, Hoffman C and Clapp B: Alternative strategies for vaccination to brucellosis. Microbes Infect. 20:599–605. 2018. View Article : Google Scholar :
28	Kostoff RN, Goumenou M and Tsatsakis A: The role of toxic stimuli combinations in determining safe exposure limits. Toxicol Rep. 5:1169–1172. 2018. View Article : Google Scholar
29	Tsatsakis A, Petrakis D, Nikolouzakis TK, Docea AO, Calina D, Vinceti M, Goumenou M, Kostoff RN, Mamoulakis C, Aschner M and Hernández AF: COVID-19, an opportunity to reevaluate the correlation between long-term effects of anthropogenic pollutants on viral epidemic/pandemic events and prevalence. Food Chem Toxicol. 141:1114182020. View Article : Google Scholar : PubMed/NCBI
30	Iddir M, Brito A, Dingeo G, Fernandez Del Campo SS, Samouda H, La Frano MR and Bohn T: Strengthening the immune system and reducing inflammation and oxidative stress through diet and nutrition: Considerations during the COVID-19 Crisis. Nutrients. 12:122020. View Article : Google Scholar
31	Nilashi M, Samad S, Yusuf SYM and Akbari E: Can complementary and alternative medicines be beneficial in the treatment of COVID-19 through improving immune system function? J Infect Public Health. 13:893–896. 2020. View Article : Google Scholar : PubMed/NCBI
32	Cunningham-Rundles S, McNeeley DF and Moon A: Mechanisms of nutrient modulation of the immune response. J Allergy Clin Immunol. 115:1119–1128; quiz 1129. 2005. View Article : Google Scholar : PubMed/NCBI
33	Mainardi T, Kapoor S and Bielory L: Complementary and alternative medicine: Herbs, phytochemicals and vitamins and their immunologic effects. J Allergy Clin Immunol. 123:283–294; quiz 295-296. 2009. View Article : Google Scholar : PubMed/NCBI
34	Jahns L, Conrad Z, Johnson LK, Whigham LD, Wu D and Claycombe-Larson KJ: A diet high in carotenoid-rich vegetables and fruits favorably impacts inflammation status by increasing plasma concentrations of IFN-α2 and decreasing MIP-1β and TNF-α in healthy individuals during a controlled feeding trial. Nutr Res. 52:98–104. 2018. View Article : Google Scholar : PubMed/NCBI
35	Majde JA and Krueger JM: Links between the innate immune system and sleep. J Allergy Clin Immunol. 116:1188–1198. 2005. View Article : Google Scholar : PubMed/NCBI
36	Chandra RK: Nutrition, immunity and infection: From basic knowledge of dietary manipulation of immune responses to practical application of ameliorating suffering and improving survival. Proc Natl Acad Sci USA. 93:14304–14307. 1996. View Article : Google Scholar : PubMed/NCBI
37	Briguglio M, Pregliasco FE, Lombardi G, Perazzo P and Banfi G: The malnutritional status of the host as a virulence factor for new coronavirus SARS-CoV-2. Front Med (Lausanne). 7:1462020.
38	Marcos A, Nova E and Montero A: Changes in the immune system are conditioned by nutrition. Eur J Clin Nutr. 57(Suppl 1): S66–S69. 2003. View Article : Google Scholar : PubMed/NCBI
39	Langley-Evans SC and Carrington LJ: Diet and the developing immune system. Lupus. 15:746–752. 2006. View Article : Google Scholar : PubMed/NCBI
40	Yang H, Sun Y, Cai R, Chen Y and Gu B: The impact of dietary fiber and probiotics in infectious diseases. Microb Pathog. 140:1039312020. View Article : Google Scholar
41	Saeed F, Nadeem M, Ahmed RS, Nadeem MT, Arshad MS and Ullah A: Studying the impact of nutritional immunology underlying the modulation of immune responses by nutritional compounds - a review. Food Agric Immunol. 27:205–229. 2016. View Article : Google Scholar
42	Davison G, Kehaya C and Wyn Jones A: Nutritional and physical activity interventions to improve immunity. Am J Lifestyle Med. 10:152–169. 2014. View Article : Google Scholar : PubMed/NCBI
43	Skalny AV, Rink L, Ajsuvakova OP, Aschner M, Gritsenko VA, Alekseenko SI, Svistunov AA, Petrakis D, Spandidos DA, Aaseth J, et al: Zinc and respiratory tract infections: Perspectives for COVID-19 (Review). Int J Mol Med. 46:17–26. 2020.